Skip to main content
Helixmith Co., Ltd logo

Helixmith Co., Ltd — Investor Relations & Filings

Ticker · 084990 ISIN · KR7084990001 KO Manufacturing
Open in API
Filings indexed 508 across all filing types
Latest filing 2020-03-30 Annual Report
Country KR South Korea
Listing KO 084990

About Helixmith Co., Ltd

https://www.helixmith.com/

Helixmith is a biotechnology company specializing in the research and development of gene therapies. Established in 1996, the company focuses on creating innovative biopharmaceuticals for diseases with significant unmet medical needs. Its core activities revolve around an extensive pipeline of next-generation gene therapy products. The primary therapeutic areas of focus include neurological and cardiovascular disorders, such as peripheral artery disease and coronary artery disease. Helixmith manages a comprehensive range of capabilities, from discovery and preclinical studies to clinical development of its drug candidates.

Recent filings

Filing Released Lang Actions
사업보고서 (2019.12)
Annual Report Classification · 100% confidence The document is a comprehensive 'Business Report' (사업보고서) for the fiscal year 2019 (Jan 1, 2019 to Dec 31, 2019) for the company Helixmith (formerly Viromed). It contains detailed financial information, business overviews, management discussions, and corporate governance details, which are the standard components of an annual report in the South Korean regulatory framework (DART). It is not an announcement or a summary, but the full report itself. FY 2019
2020-03-30 Korean
[기재정정]주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) issued by Helixmith (formerly ViroMed). It contains the agenda for the upcoming Annual General Meeting (AGM), including items such as financial statement approval, director appointments, and amendments to the articles of incorporation. It also includes 'Management Reference Materials' (경영참고사항) required by law to be provided to shareholders prior to the meeting. This document is a formal proxy statement/information circular sent to shareholders to solicit votes and provide meeting details, which falls under the Proxy Solicitation & Information Statement category.
2020-03-25 Korean
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Proxy Solicitation' (참고서류) filed by Helixmith (formerly Viromed) in preparation for its 24th Annual General Meeting. It contains detailed information regarding the meeting agenda, proposed changes to the articles of incorporation, and financial statements (balance sheets) to be approved by shareholders. This document is designed to provide shareholders with the necessary information to exercise their voting rights, which fits the definition of a Proxy Solicitation & Information Statement.
2020-03-25 Korean
기타경영사항(특허권취득)(자율공시)(간세포 성장인자의 둘 이상의 이형체를 이용한 근위축성 측삭경화증(ALS) 예방 또는 치료용 조성물)
Regulatory Filings Classification · 95% confidence The document is a regulatory disclosure from Helixmith regarding the acquisition of a patent for an ALS treatment. It is a voluntary disclosure (자율공시) of a specific corporate event (patent acquisition). Since it does not fit into specific categories like financial reports, board changes, or shareholder meetings, and is a standard regulatory announcement of a material event, it falls under the general regulatory filing category.
2020-03-25 Korean
감사보고서제출
Audit Report / Information Classification · 98% confidence The document is a formal regulatory filing titled 'Audit Report Submission' (감사보고서 제출) from Helixmith. It provides a summary of financial data, audit opinions, and key financial metrics (assets, liabilities, profit/loss) for the fiscal year. While it contains financial data, it is a standard regulatory disclosure announcement in Korea (DART system style) notifying the market that the audit report has been submitted, rather than the full 10-K annual report document itself. Following the 'Menu vs Meal' rule, this is classified as a Report Publication Announcement. FY 2019
2020-03-23 Korean
[기재정정]감사보고서제출
Audit Report / Information Classification · 98% confidence The document is a formal regulatory filing from Helixmith titled 'Audit Report Submission' (감사보고서 제출). It provides the financial highlights, audit opinions, and key financial metrics (assets, liabilities, profit/loss) for the fiscal year, as required by regulatory standards. While it contains financial data, it is a structured disclosure of the audit results rather than the full 10-K annual report itself. Given the specific nature of audit report disclosures in the Korean market (DART system), this falls under the 'Audit Report / Information' category. FY 2019
2020-03-23 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.